Eos Advisory
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
EnsiliTech raises £4.5m seed round led by Eos Advisory to transform global medicine storage and transport
EnsiliTech develops technology that stabilises vaccines and biologics at high temperatures, removing the need for cold-chain storage and improving global access to medicines.
Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies
Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.
Concinnity Genetics raises £3m seed round led by Eos Advisory to establish RNA-based gene therapy control systems
Concinnity Genetics develops RNA based control systems that allow gene and cell therapies to be adjusted after dosing, improving safety and flexibility in advanced medical treatments.
Naturbeads lands £8m Series A led by EOS to tackle microplastic pollution with sustainable cellulose microspheres
Naturbeads produces biodegradable cellulose microspheres that replace microplastics in everyday products, enabling manufacturers to meet regulatory requirements without compromising performance.
More venture news
- 2 Mar 2026
Payr raises a £1.5m seed round led by Ingenii Capital for credit card-enabled rent payments
SeedFintech - 2 Mar 2026
Ivee raises a seven-figure seed round from Social Impact Enterprises and angels for AI upskilling and talent platform
SeedHR - 25 Feb 2026
Kinfolk raises a £5m seed round led by AlbionVC to shift manual HR workflows with agentic AI
SeedHR
